SCHEMBL4057029

SCHEMBL4057029

CC(C)(C)OC(=O)CCc1ccc2cc(OC(=O)OC(C)(C)C)ccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
MAPT P10636 2/20 0.49
NPC1 O15118 1/20 0.49
LMNA P02545 1/20 0.49
TP53 P04637 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAOA P21397 1/20 0.49
SLC6A2 P23975 1/20 0.49
RAB9A P51151 1/20 0.49
SLC6A3 Q01959 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ELANE P08246 1/20 0.47
CA2 P00918 1/20 0.41
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
HIF1A Q16665 1/20 0.40
HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29059895 0.87 ELANE (0.57) MAPTLMNAELANEALDH1A1NR1H2
SCHEMBL4548369 0.86 MAPT (0.67) KDM4EMAPTNPC1LMNATP53
SCHEMBL4062344 0.83 ELANE (0.53) ELANENR1H2NR1H3KDM1A
SCHEMBL29059942 0.83 CYP1A2 (0.53) KDM4EMAPTNPC1LMNATP53
SCHEMBL4065911 0.83 THRB (0.50) KDM4EMAPTNPC1LMNATP53
SCHEMBL4061539 0.82 ELANE (0.65) KDM4EMAPTLMNASMN1; SMN2ELANE
SCHEMBL10312507 0.82 LMNA (0.46) KDM4EMAPTNPC1LMNATP53
SCHEMBL22504317 0.77 TRPV1 (0.43) KDM4EMAPTNPC1LMNATP53
SCHEMBL10982252 0.77 CYP4F2 (0.50) ALDH1A1MTNR1AMTNR1BNR1H2NR1H3
SCHEMBL27680586 0.76 KMT2A (0.51) RAB9AELANEHPGDAKR1C3NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM KDM4E 1317/4885MAPT 3954/4885NPC1 3547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.